(3β,5α)5,8-[N,N-(4-Phenylurazole)]-cholest-6,22-diene-3,25-diol-d6
| Product Name |
(3β,5α)5,8-[N,N-(4-Phenylurazole)]-cholest-6,22-diene-3,25-diol-d6
|
| Product Code |
DA-E105-19
|
| Chemical name |
(3β,5α)5,8-[N,N-(4-Phenylurazole)]-cholest-6,22-diene-3,25-diol-d6
|
| Synonyms |
[4aS-[4aα,6α,8aα,8bβ,10aα,11α(1S*,2E,4R*),13aβ,13bα]]-5,6,7,8,8a,8b,10,10a,11,12,13,13a-Dodecahydro-6-hydroxy-11-(5-hydroxy-1,4,5-trimethyl-2-hexenyl)-8a,10a-dimethyl-2-phenyl-4a,13b-etheno-1H,9H-benzo[c]cyclopenta[h][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H)-dione-d6
|
| Impurity |
NA
|
| CAS Number |
NA
|
| Alternate CAS # |
NA
|
| Molecular form |
C36H43D6N3O4
|
| Appearance |
White Solid
|
| Melting Point |
NA
|
| Mol. Weight |
593.83
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
chiral standards,stable isotopes,pharmaceutical standards,intermediates,fine chemicals,steroids
|
| Boiling Point |
NA
|
| Applications |
Intermediate in the preparation of labelled Vitamin D2 and its derivatives.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
